Mechanistic Considerations About an Unexpected Ramipril Drug‐Drug Interaction in the Development of a Triple Fixed‐Dose Combination Product Containing Ramipril, Amlodipine, and Atorvastatin
Author:
Affiliation:
1. Clinical Research Appliance (cr.appliance) Gelnhausen Germany
2. Midas Pharma GmbH Ingelheim Germany
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.930
Reference23 articles.
1. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990‐2017: a systematic analysis for the Global Burden of Disease Study 2017;GBD 2017 Risk Factor Collaborators;Lancet,2018
2. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study
3. A strategy to reduce cardiovascular disease by more than 80%
4. The Concept of the Polypill in the Prevention of Cardiovascular Disease
5. Effectiveness of fixed dose combination medication (‘polypills’) compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3